Today: 9 June 2026
Archer Aviation stock jumps 8% as air-taxi shares rally — what’s driving ACHR now
3 January 2026
1 min read

Archer Aviation stock jumps 8% as air-taxi shares rally — what’s driving ACHR now

NEW YORK, January 3, 2026, 07:16 ET — Market closed

  • Archer Aviation shares closed up about 8% on Friday, the last U.S. session, on heavy volume.
  • A Form 144 filing showed an insider planned to sell 125,000 shares under SEC Rule 144.
  • Traders are eyeing U.S. data next week, including ISM manufacturing and the Jan. 9 jobs report.

Archer Aviation Inc (ACHR) shares climbed 8.4% in the latest session, closing at $8.13 on Friday. The stock swung between $7.51 and $8.20 and traded about 45 million shares.

The jump highlights how quickly sentiment can shift in early-stage aviation plays at the start of the year. Archer is still in development, so much of its valuation rests on expectations for future operations rather than current revenue.

Investors also face a packed calendar that could steer interest-rate bets, a key driver for high-growth stocks. “The market is looking for direction,” Matthew Maley, chief market strategist at Miller Tabak, said in comments reported by Reuters. Reuters

Archer’s move tracked gains across electric vertical takeoff and landing, or eVTOL, developers. Joby Aviation rose 8.8% on Friday, while Vertical Aerospace gained 9.7%.

MarketBeat pegged Archer’s volume at about 44.5 million shares, roughly 41% above its average daily turnover.

A Form 144 filing showed Archer insider Thomas Muniz planned to sell 125,000 Class A shares, with an aggregate market value of $1 million, through Fidelity Brokerage Services, with an approximate sale date of Jan. 2. Form 144 is a notice required before a planned sale under SEC Rule 144, which governs resales of restricted or control shares.

Such notices do not guarantee a transaction, but they can influence sentiment in fast-moving stocks where liquidity can thin out quickly.

Archer is developing eVTOL aircraft for short-distance urban flights, a field drawing intense investor interest but still dependent on certification and manufacturing scale-up. The companies are typically pre-revenue and rely on funding to cover engineering, regulatory work and factory build-outs.

That puts a premium on regulatory milestones and cash runway — how long cash can last at the current spending pace. It also leaves the shares sensitive to changes in bond yields, which can shift investors’ appetite for risk.

Before Monday’s session, investors will parse the ISM manufacturing purchasing managers’ index, or PMI, due at 10 a.m. ET. The PMI is a survey-based gauge of factory activity that can move yields and rate-cut expectations.

Later in the week, attention turns to the labor market and inflation, which can matter even more for high-beta stocks — those that tend to swing more than the broader market. The Bureau of Labor Statistics schedules the December jobs report for Jan. 9 and the CPI release for Jan. 13.

Stock Market Today

  • Wheat Futures Rise as Export Inspections Show Mixed Data
    June 9, 2026, 9:19 AM EDT. Wheat futures gained on Monday, with Chicago SRW up 5-7 cents, KC HRW up 9-11 cents, and MPLS spring wheat rising slightly. Export inspections reported 319,730 MT shipped in the week ending June 4, down 20.65% from the previous week and 1.38% below last year. Mexico led exports with 83,211 MT. Managed money increased net shorts in Chicago wheat futures to 57,871 contracts, hitting a record bear move since 2006. Ukraine's wheat crop estimate rose 1.8 MMT to 21.7 MMT. July 26 CBOT Wheat futures closed at $5.86 ½, up 6 ½ cents, reflecting bullish momentum amid volatile trading conditions.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
Carvana stock drops 5% after insider sale filings; what CVNA investors watch next week
Previous Story

Carvana stock drops 5% after insider sale filings; what CVNA investors watch next week

Quantum computing stocks surge to start 2026: D-Wave, Rigetti, IonQ lead — what investors watch next
Next Story

Quantum computing stocks surge to start 2026: D-Wave, Rigetti, IonQ lead — what investors watch next

Go toTop